These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32591643)
1. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models. Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643 [No Abstract] [Full Text] [Related]
2. TLX1-induced T-cell acute lymphoblastic leukemia. De Keersmaecker K; Ferrando AA Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691 [TBL] [Abstract][Full Text] [Related]
4. The TLX1 oncogene drives aneuploidy in T cell transformation. De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433 [TBL] [Abstract][Full Text] [Related]
5. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia. Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177 [TBL] [Abstract][Full Text] [Related]
6. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy. De Keersmaecker K Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526 [No Abstract] [Full Text] [Related]
7. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing. Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933 [No Abstract] [Full Text] [Related]
8. MEIS proteins as partners of the TLX1/HOX11 oncoprotein. Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479 [TBL] [Abstract][Full Text] [Related]